Bacitracin

Cyclic Peptide AntibioticRx: OtcCompound: Approved

Also known as: BAC, Baciguent, BACiiM, Bacitracin A, Bacitracin zinc, Bacitracin-Polymyxin B, Neosporin (combination), Polysporin (combination)

Educational Only — Not medical advice. Consult a qualified clinician before using any peptide.

Source Bacitracin at Peptiology

Save 10% with code PEPTI-BOSSRABBIT-10

Shop Now & Save 10% →

Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.

Summary

Bacitracin is a mixture of cyclic polypeptide antibiotics used topically for superficial skin infections; systemic use is limited due to nephrotoxicity.

Mechanism of Action

Inhibits bacterial cell wall synthesis by blocking dephosphorylation of bactoprenol phosphate, preventing peptidoglycan precursor translocation.

Routes of Administration

IntramuscularIntravenousOphthalmicOralTopical

Goals & Uses

  • Treatment of superficial skin infectionsAntimicrobialHigh
  • Clostridium difficile infection (oral)Antimicrobial / GILow
  • Systemic gram-positive infections (IM)Antimicrobial / SystemicLow
  • Prevention of minor skin infectionAntimicrobial / Wound CareHigh
  • Ophthalmic infections (conjunctivitis, blepharitis)Antimicrobial / OphthalmologyModerate
  • treat superficial bacterial skin infectionsAntibacterialHigh

Contraindications

  • hypersensitivity to bacitracinAllergyHigh
  • Deep wounds, puncture wounds, or serious burns (OTC topical)Wound TypeModerate
  • Severe renal impairment (systemic use)Organ ImpairmentModerate
  • Known hypersensitivity to bacitracinAllergyHigh
  • Renal impairment (systemic/IM use)RenalHigh

Adverse Effects

  • AnaphylaxisImmunologicRareSevere life-threatening allergic reaction
  • Contact dermatitis / Allergic sensitizationDermatologic / ImmunologicUncommon
  • Contact dermatitisDermatologicalCommon
  • Nausea/vomitingGastrointestinalRare
  • Nausea and vomitingGastrointestinalUncommon
  • Local injection site painLocal ReactionCommon
  • Neuromuscular blockadeNeuromuscularRare
  • NephrotoxicityRenalUncommon

Drug Interactions

  • Loop diureticsLow
  • Colistin / PolymyxinsModerate
  • AminoglycosidesModerate
  • Neuromuscular blocking agents (e.g., succinylcholine, vecuronium)High
  • Other nephrotoxic agents (e.g., aminoglycosides, vancomycin, NSAIDs)High

Population Constraints

  • PregnancyReproductive SafetyRelative
  • Neonates (systemic use)PediatricRelative
  • Patients with renal impairmentOrgan ImpairmentAbsolute
  • Large surface area applicationSpecial UseRelative
  • Pregnant womenReproductiveRelative
  • NeonatesPediatricRelative

Regulatory Status

  • European UnionApprovedApproved: topical treatment of minor skin infectionsAvailable as OTC ointment; systemic use restricted.
  • United StatesApprovedApproved: topical treatment of minor skin infectionsOTC for topical formulations; intravenous use is investigational/compounded.
  • United KingdomApprovedApproved: Topical skin and wound infections, Ophthalmic infectionsAvailable OTC and as prescription topical/ophthalmic preparations in the UK.

FDA-approved for topical and ophthalmic use OTC; intramuscular formulation is prescription-only and rarely used due to nephrotoxicity risk. Banned as a livestock feed additive in the EU. WHO classifies bacitracin as 'not critically important' for human medicine.

Evidence & Sources

No sources recorded yet.

Frequently Asked Questions

What is Bacitracin?

Bacitracin is a mixture of cyclic polypeptide antibiotics used topically for superficial skin infections; systemic use is limited due to nephrotoxicity.

What is Bacitracin used for?

Bacitracin is educationally associated with: Treatment of superficial skin infections, Clostridium difficile infection (oral), Systemic gram-positive infections (IM), Prevention of minor skin infection, Ophthalmic infections (conjunctivitis, blepharitis), treat superficial bacterial skin infections. Educational only — not medical advice.

How is Bacitracin administered?

Recorded routes of administration: Intramuscular, Intravenous, Ophthalmic, Oral, Topical.

What are the potential side effects of Bacitracin?

Reported adverse effects include: Anaphylaxis, Contact dermatitis / Allergic sensitization, Contact dermatitis, Nausea/vomiting, Nausea and vomiting, Local injection site pain, Neuromuscular blockade, Nephrotoxicity. This list is not exhaustive — consult a qualified clinician.

Who should avoid Bacitracin?

Recorded contraindications: hypersensitivity to bacitracin, Deep wounds, puncture wounds, or serious burns (OTC topical), Severe renal impairment (systemic use), Known hypersensitivity to bacitracin, Renal impairment (systemic/IM use). Consult a qualified clinician before use.

More in this class